1077MO PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study.
Saved in:
| Title: | 1077MO PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study. |
|---|---|
| Authors: | Delyon, J.1 (AUTHOR), Resche-Rigon, M.2 (AUTHOR), Renaud, M.1 (AUTHOR), Le Goff, J.3 (AUTHOR), Dalle, S.4 (AUTHOR), Heidelberger, V.5 (AUTHOR), Da Meda, L.1 (AUTHOR), Allain, V.6 (AUTHOR), Toullec, L.6 (AUTHOR), Carcelain, G.7 (AUTHOR), Mourah, S.8 (AUTHOR), Caillat-Zucman, S.6 (AUTHOR), Battistella, M.9 (AUTHOR), Lebbé, C.10 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS732-S732. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2020.08.1201 |
